Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

A Quick Recap from ASCO GU 2023: Prostate and U...

The ASCO Genitourinary (GU) Cancers Symposium, which ended on February 18, 2023, was a three-day scientific and educational meeting designed to provide attendees with in-depth, multidisciplinary an...

Feb 24, 2023

top-10-oncology-drugs-launches-2023
Top 10 Expected Oncology Drug Launches in 2023

Cancer is the world’s second leading cause of death. Every year, 10 million people die from cancer. Cancer kills 70% of people in low-to-middle-income countries. Cancer is estimated to cost the global economy USD 1.16 trillion per year. Millions of lives could be saved annually by implementing resource-appropriate ...

Find More
Protein Supplements Market, Growing Demand, and Key Companies
How is Protein Supplements Market Evolving with the Ongoing Development?

Protein supplements are critical in building and repairing muscles and maintaining their growth. People from specific groups, such as athletes and fitness enthusiasts, rely heavily on essential nutrients to build muscle and recover faster after intense workouts. Moreover, protein supplements are also beneficial for...

Find More
donanemab-for-alzheimers-disease-treatment
The Road Ahead for Donanemab: Will the Therapy be the Next Imminent Breakthrough in the Alzheimer’s Disease Treatment Landscape?

Alzheimer’s disease (AD) is becoming a rapidly growing public health concern due to the rise in the world’s aging population. Based on the data obtained from the 2019 Global Burden of Disease (GBD) database, the incidence and prevalence of Alzheimer’s disease and other dementias increased by 147.95 and 160.84%, res...

Find More

More Views & Analysis

epstein-barr-virus-ebv-treatment-outlook
Changing Landscape of EBV-associated Diseases Treatment: Is T-cell Immunotherapy the Answer?

Epstein–Barr virus (EBV), also known as human herpesvirus 4 (HHV-4), was discovered in the 1960s as an inescapable virus that infects almost 95% of the world’s population and causes nearly 1% of all cancers. Besides, the virus is a leading cause of infectious mononucleosis (IM) and is associated with different subt...

Find More

Pacemakers Market and Assessment of Trends, Developments, Growth
Pacemakers: Analyzing the Market Dynamics and Major Developments

Over the past few decades, the prevalence of cardiovascular diseases has grown significantly, leading to very high mortality and morbidity worldwide. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other condition...

Find More

ppar-and-nox-agonist-for-primary-biliary-cholangitis-treatment
PPAR and NOX Agonist: Savior of Underserved Primary Biliary Cholangitis Patients

Primary biliary cholangitis (PBC), earlier known as primary biliary cirrhosis, is an autoimmune disorder that leads to the gradual destruction of intrahepatic bile ducts resulting in periportal inflammation cholestasis. Prolonged hepatic cholestasis subsequently leads to cirrhosis and portal hypertension. As per...

Find More

Biologics in the Nasal Polyposis Treatment Market
Biologics Spark Market Interest In The Nasal Polyposis Treatment Space

A highly prevalent condition, Nasal polyps are benign growths in the mucosa of the nose that blocks the nasal passageway, reducing the quality of life (QoL), causing hyposmia or anosmia and sleep disturbances in those affected. Often associated with chronic nasal inflammation and conditions like asthma, these are a...

Find More

Biochips Market Trends, Growth, Development, and Forecast
Biochips: An Evolving Technology Driving the Future of Healthcare Market

Technological advancements over the past few decades have significantly transformed our lives and are anticipated to exhibit the trends in the upcoming years. Our living today is simplified to a much larger extent, which seemed unrealistic to imagine over the past few years. With each passing day, technological inn...

Find More

mercks-gefapixant-for-crc-treatment
Will Merck’s P2X3 Receptor Antagonist for Chronic Refractory Cough Treatment Be Able to Turn FDA’s Nay Into Yea?

Patients who are battling this crippling ailment find that chronic refractory cough (CRC), also known as refractory chronic cough (RCC) or unexplained chronic cough (UCC), proves to be a major burden. DelveInsight’s analysis estimates that in the US, there were approximately 12.7 million 12-month prevalent episodes...

Find More

Postoperative Pain is the pain that an individual experiences after a major operation or surgical pr.....

Find More

HIV-associated lipodystrophy (HAL), is a condition characterized by the redistribution of adipose ti.....

Find More

It was assumed initially that Alzheimer’s Disease was a rare condition, but now it is considered t.....

Find More

Over the years, the Oncology domain has experienced the entry of several treatment approaches. Thera.....

Find More

Today, the sedentary lifestyle adopted among people has led to cause a myriad of underlying diseases.....

Find More

Cystic fibrosis (CF) is a hereditary condition leading to chronic lung infections and eventually dec.....

Find More